Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion type Assertion NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_head.
- NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion description "[IL-17A serum concentrations were 5767 � 2700 pg/ml (mean � SEM) in sALS patients and 937 � 927 pg/ml in fALS patients in comparison to 7 � 2 pg/ml in control subjects without autoimmune disorders (p = 0.008 ALS patients vs. control subjects by Mann-Whitney test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_provenance.
- NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion evidence source_evidence_literature NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_provenance.
- NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion SIO_000772 21062492 NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_provenance.
- NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion wasDerivedFrom befree-2016 NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_provenance.
- NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_assertion wasGeneratedBy ECO_0000203 NP851340.RAGelrFVURKJw1bg7Qu9t78xHeVIUETW8GxIL0zLd-vCw130_provenance.